Back
HFA Premium Access

Baseline cardiovascular comorbidities in patients with hematological malignancies who receive cardiotoxoc treatment and possible cardiotoxic effects-the experience of our hospital

Session: ePosters in cardiovascular disease in special populations 2
Topic: Cardio-Oncology
Speaker: Doctor M. Stratinaki (Heraklion, GR)
Event: Heart Failure 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Maria Stratinaki

Venizelio General Hospital, Heraklion (Greece)
9 presentations
0 follower

6 more presentations in this session

A right ventricular function study in a group of breast cancer patients undergoing chemotherapy

Speaker: Doctor M. Castro (Guimaraes, PT)

Access
Abstract
Slides
Like
Thumbnail

Association between beta-1-blockers and reduced efficacy of pembrolizumab in non-small cell lung cancer

Speaker: Doctor M. Laufer-Perl (Tel Aviv, IL)

Access
Abstract
Slides
Like
Thumbnail

Diastolic dysfunction is associated with development of heart failure in patients with breast cancer under chemotherapy

Speaker: Doctor M. Castro (Guimaraes, PT)

Access
Abstract
Slides
Like
Thumbnail

The beneficial role of cardioprotective drugs in preventing cardiotoxicity in HER2 positive breast cancer, an echocardiographic point-of-view

Speaker: Doctor C. Oliveira (Porto, PT)

Access
Abstract
Slides
Like
Thumbnail

Cardiotoxicity assessment according to current cardio-cncology guidelines in a population of female breast cancer patients

Speaker: Doctor C. Oliveira (Porto, PT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

ePosters in cardiovascular disease in special populations 2

Speakers: Doctor M. Stratinaki, Doctor M. Castro, Doctor M. Laufer-Perl, Doctor M. Castro, Doctor C. Oliveira...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources